Hong Kong Pharma Digital Technology Holdings Limited
HKPD · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | |
|---|---|---|---|
| Revenue | $20 | $17 | $13 |
| % Growth | 21.7% | 32.9% | – |
| Cost of Goods Sold | $18 | $13 | $10 |
| Gross Profit | $2 | $4 | $3 |
| % Margin | 11.9% | 21.3% | 21.8% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 |
| Operating Expenses | $2 | $2 | $2 |
| Operating Income | $0 | $2 | $1 |
| % Margin | 0.6% | 9.6% | 8.3% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 |
| Pre-Tax Income | $0 | $2 | $1 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | -$0 | $1 | $1 |
| % Margin | -0.1% | 8% | 7.9% |
| EPS | -0.003 | 0.18 | 0.091 |
| % Growth | -101.5% | 98.5% | – |
| EPS Diluted | -0.003 | 0.18 | 0.091 |
| Weighted Avg Shares Out | 9 | 7 | 11 |
| Weighted Avg Shares Out Dil | 10 | 7 | 11 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $1 | $1 | $1 |
| EBITDA | $1 | $3 | $2 |
| % Margin | 5.9% | 15.2% | 14% |